BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30323565)

  • 1. Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway.
    Chen L; Wang J; Wu J; Zheng Q; Hu J
    Drug Des Devel Ther; 2018; 12():3335-3342. PubMed ID: 30323565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell.
    Zhang X; Song Y; Wu Y; Dong Y; Lai L; Zhang J; Lu B; Dai F; He L; Liu M; Yi Z
    Int J Cancer; 2011 Nov; 129(10):2502-11. PubMed ID: 21207415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.
    Zhao X; Guo X; Shen J; Hua D
    Mol Med Rep; 2018 Oct; 18(4):4030-4036. PubMed ID: 30132572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.
    Huang W; Liu Y; Wang J; Yuan X; Jin HW; Zhang LR; Zhang JT; Liu ZM; Cui JR
    Eur J Med Chem; 2018 Sep; 157():887-897. PubMed ID: 30145375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
    Yuan S; Xu Y; Yi T; Wang H
    J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway.
    Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
    Nam S; Buettner R; Turkson J; Kim D; Cheng JQ; Muehlbeyer S; Hippe F; Vatter S; Merz KH; Eisenbrand G; Jove R
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5998-6003. PubMed ID: 15837920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).
    Scobie MR; Houke HR; Rice CD
    Chem Biol Interact; 2019 Oct; 312():108816. PubMed ID: 31505164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fraxetin suppresses the proliferation, migration, and invasion of ovarian cancer cells by inhibiting the TLR4/STAT3 signaling pathway.
    Xu R; Ruan Y; Zhang L; Gu Y; Liu M
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):287-294. PubMed ID: 36346016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling.
    Liu L; Kritsanida M; Magiatis P; Gaboriaud N; Wang Y; Wu J; Buettner R; Yang F; Nam S; Skaltsounis L; Jove R
    Cancer Biol Ther; 2012 Nov; 13(13):1255-61. PubMed ID: 22895078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D
    Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
    Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells.
    Liu Y; Peng X; Li H; Jiao W; Peng X; Shao J; Xu Y; Wang R; Wang W; Kong D
    Recent Pat Anticancer Drug Discov; 2021; 16(3):350-362. PubMed ID: 33655847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling.
    Zhang Y; Du Z; Zhuang Z; Wang Y; Wang F; Liu S; Wang H; Feng H; Li H; Wang L; Zhang X; Hao A
    J Neurooncol; 2015 Nov; 125(2):265-75. PubMed ID: 26386687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
    Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
    Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 17. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.
    Duan Z; Ames RY; Ryan M; Hornicek FJ; Mankin H; Seiden MV
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):681-9. PubMed ID: 18587580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.
    Wen W; Wu J; Liu L; Tian Y; Buettner R; Hsieh MY; Horne D; Dellinger TH; Han ES; Jove R; Yim JH
    Mol Cancer; 2015 May; 14():100. PubMed ID: 25928246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells.
    Liu L; Gaboriaud N; Vougogianopoulou K; Tian Y; Wu J; Wen W; Skaltsounis L; Jove R
    Cancer Biol Ther; 2014 Feb; 15(2):178-84. PubMed ID: 24100507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.